Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine as an Adjuvant for Ultrasound Guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Tumor: A Prospective Randomized Controlled Trial

NCT07878156 is registered in ClinicalTrials.gov with Children's Cancer Hospital Egypt 57357 as lead sponsor.

NCT NCT07878156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07878156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine as an Adjuvant for Ultrasound Guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Tumor: A Prospective Randomized Controlled Trial
Lead sponsor
Children's Cancer Hospital Egypt 57357
Phase
Phase 3
Overall status
Recruiting
Start date
December 17, 2025
Completion date
March 31, 2027
Enrollment
260 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posterior fossa tumor